These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 30385238

  • 1. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D, Hu S, Sun J, Zhang L, Dong H, Feng W, Lei J, Dong Y.
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [Abstract] [Full Text] [Related]

  • 2. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y.
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [Abstract] [Full Text] [Related]

  • 3. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
    Liang C, Zhang X, Zhou L, Meng G, Zhong L, Peng P.
    BMC Infect Dis; 2021 May 17; 21(1):444. PubMed ID: 34001022
    [Abstract] [Full Text] [Related]

  • 4. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
    Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y.
    BMC Infect Dis; 2020 Apr 07; 20(1):269. PubMed ID: 32264851
    [Abstract] [Full Text] [Related]

  • 5. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL, Hu LM, Xie ZZ, Dong YW, Dong L.
    Zhonghua Er Ke Za Zhi; 2019 Jul 02; 57(7):553-558. PubMed ID: 31269557
    [Abstract] [Full Text] [Related]

  • 6. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC, Shi ZY, Chen YH, Wang FD.
    J Microbiol Immunol Infect; 2016 Feb 02; 49(1):74-82. PubMed ID: 26586483
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A, Soysal A, Altinkanat Gelmez G, Kepenekli Kadayifci E, Söyletir G, Bakir M.
    J Hosp Infect; 2016 Jan 02; 92(1):67-72. PubMed ID: 26601601
    [Abstract] [Full Text] [Related]

  • 8. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP.
    PLoS One; 2018 Jan 02; 13(4):e0195757. PubMed ID: 29649276
    [Abstract] [Full Text] [Related]

  • 9. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    Lew KY, Ng TM, Tan M, Tan SH, Lew EL, Ling LM, Ang B, Lye D, Teng CB.
    J Antimicrob Chemother; 2015 Apr 02; 70(4):1219-25. PubMed ID: 25473028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M.
    Diagn Microbiol Infect Dis; 2017 Apr 02; 87(4):359-364. PubMed ID: 28089138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidemiology of carbapenem-resistant Gram-negative infections globally.
    Brink AJ.
    Curr Opin Infect Dis; 2019 Dec 02; 32(6):609-616. PubMed ID: 31567571
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    Guo W, He Q, Wang Z, Wei M, Yang Z, Du Y, Wu C, He J.
    Am J Infect Control; 2015 Apr 01; 43(4):358-64. PubMed ID: 25838134
    [Abstract] [Full Text] [Related]

  • 18. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ, Hellenic Cefiderocol Study Group.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1704-1708. PubMed ID: 28369471
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
    Jean SS, Hsueh PR, Lee WS, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Lam C, Chen RJ.
    Int J Antimicrob Agents; 2013 May 01; 41(5):457-62. PubMed ID: 23507415
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
    Kim T, Chong YP, Park SY, Jeon MH, Choo EJ, Chung JW, Lee HK, Moon C, Kim DM, Peck KR, Kim YS.
    Diagn Microbiol Infect Dis; 2014 Apr 01; 78(4):457-61. PubMed ID: 24462178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.